Sponsor Pipeline

Sanaria Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT07675785
PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-28 NCT07730177 Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07385287 Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults Malaria (Plasmodium Falciparum) Recruiting
NCT07675785 PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali Malaria (Plasmodium Falciparum) Recruiting
Phase 1
NCT06862453 Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve… Malaria Falciparum Recruiting
NCT07730177 Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso Malaria (Plasmodium Falciparum) Not Yet Recruiting
Get alerts when Sanaria Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free